Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TFPI | P10646 | 1/20 | 0.73 |
| ▸ | VIPR1 | P32241 | 4/20 | 0.66 |
| ▸ | VIPR2 | P41587 | 6/20 | 0.63 |
| ▸ | KISS1R | Q969F8 | 2/20 | 0.61 |
| ▸ | PTH1R | Q03431 | 1/20 | 0.60 |
| ▸ | ECE1 | P42892 | 1/20 | 0.60 |
| ▸ | GLP1R | P43220 | 1/20 | 0.60 |
| ▸ | MUS81 | Q96NY9 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30176419 | 0.94 | VIPR1 (0.68) | TFPIVIPR1VIPR2PTH1RECE1 | |
| SCHEMBL30567756 | 0.94 | VIPR1 (0.72) | TFPIVIPR1VIPR2ECE1GLP1R | |
| SCHEMBL29519384 | 0.93 | TFPI (0.68) | TFPIVIPR1VIPR2PTH1RECE1 | |
| SCHEMBL30883219 | 0.92 | TFPI (0.67) | TFPIVIPR1GLP1R | |
| SCHEMBL30176441 | 0.92 | TFPI (0.64) | TFPIVIPR1VIPR2PTH1RECE1 | |
| SCHEMBL30601869 | 0.92 | TFPI (0.79) | TFPIVIPR1VIPR2ECE1GLP1R | |
| SCHEMBL30198769 | 0.91 | TFPI (0.65) | TFPIVIPR1VIPR2PTH1R | |
| SCHEMBL30220503 | 0.91 | TFPI (0.66) | TFPIVIPR1VIPR2PTH1RECE1 | |
| SCHEMBL31563800 | 0.91 | VIPR1 (0.73) | TFPIVIPR1VIPR2ECE1GLP1R | |
| SCHEMBL30496422 | 0.91 | TFPI (0.71) | TFPIVIPR1VIPR2PTH1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240190952-A1 | IL-18 Binding Protein (IL-18BP) and Antibodies for Treating Inflammatory Diseases | AB2 BIO SA (CH) | 2024-06-13 | — | — | US | disclosed |
| US-11926663-B2 | IL-18 binding protein (IL-18BP) and antibodies in inflammatory diseases | AB2 BIO SA (CH) | 2024-03-12 | — | — | US | disclosed |
| US-11820817-B2 | IL-18 binding protein (IL-18BP) and antibodies in inflammatory diseases | AB2 BIO SA (CH) | 2023-11-21 | — | — | US | disclosed |
| US-20230250164-A1 | IL-18 Binding Protein (IL-18BP) In Inflammatory Diseases | AB2 BIO SA (CH) | 2023-08-10 | — | — | US | disclosed |
| US-11530263-B2 | IL-18 binding protein (IL-18BP) in inflammatory diseases | AB2 BIO SA (CH) | 2022-12-20 | — | — | US | disclosed |
| EP-3978526-A1 | IL-18 BINDING PROTEIN (IL-18BP) IN INFLAMMATORY DISEASES | AB2 Bio SA (CH) | 2022-04-06 | — | — | EP | disclosed |